in malaria parasites, the systematic experimental validation of drug and vaccine targets by reverse genetics is constrained by the inefficiency of homologous recombination and by the difficulty of manipulating adenine and thymine (A+t)-rich dnA of most Plasmodium species in Escherichia coli. We overcame these roadblocks by creating a high-integrity library of Plasmodium berghei genomic dnA (>77% A+t content) in a bacteriophage n15-based vector that can be modified efficiently using the lambda red method of recombineering. We built a pipeline for generating P. berghei genetic modification vectors at genome scale in serial liquid cultures on 96-well plates. Vectors have long homology arms, which increase recombination frequency up to tenfold over conventional designs. the feasibility of efficient genetic modification at scale will stimulate collaborative, genome-wide knockout and tagging programs for P. berghei.
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Experimental genetic manipulation has had a major impact on our understanding of Plasmodium biology and pathogenesis [1] [2] [3] . However, technological roadblocks have prevented scale-up beyond a few dozen genes per study 4, 5 . In conventional protocols the genome of P. berghei is modified through homologous recombination with linear DNA fragments containing a selection cassette flanked on each side by 0.4-1.0 kilobases (kb) of sequence homologous to the target locus 6 . In other model systems, such as mouse embryonic stem cells, the routine use of much longer (up to 10 kb) homology arms has increased recombination frequency substantially 7, 8 , but generating similar vectors for use in malaria parasites has so far been impractical because the extreme A+T content of most Plasmodium sp. genomes 9, 10 renders large inserts of genomic DNA unstable in conventional bacterial plasmids and difficult to manipulate by restriction-ligation cloning. As a consequence, large-insert genomic DNA (gDNA) libraries in bacterial artificial chromosomes (BACs), which form the basis for the construction of complex genetic modification vectors for model organisms [11] [12] [13] , are not available for either P. berghei or P. falciparum.
To overcome this obstacle, here we describe the construction of a P. berghei gDNA library in a low-copy plasmid based on bacteriophage N15, which replicates in E. coli as a linear, A scalable pipeline for highly effective genetic modification of a malaria parasite 14, 15 and can carry relatively large inserts of (A+T)-rich and repetitive DNA 16 . We show that the genomic DNA inserts of the library can be modified by homologous recombination in E. coli that transiently express the recombinase complex and proofreading activity encoded by the bacteriophage lambda redγβα operon and bacterial recA under the control of the arabinose-inducible pBAD promoter 17, 18 . This technology, termed recombineering, requires only short (<50 base pairs (bp)) regions of homology, which can be included in synthetic oligonucleotides. Lambda red recombineering has been used to modify BACs from model organisms, including the related apicomplexan parasite Toxoplasma gondii 19, 20 , and its robustness and independence of restriction sites have made it the method of choice to scale up targeted gene disruption in the mouse 21 .
We developed a method to convert gDNA library inserts into gene deletion and tagging vectors for the genome-wide functional analysis of P. berghei genes. In our two-step strategy lambda red recombineering in the E. coli host is first used to introduce a bacterial selection marker into the gDNA insert, such that the target gene is either deleted or prepared for 3′-end tagging. We then replace the bacterial marker with a selection cassette for P. berghei in a Gateway LR Clonase reaction in vitro. The modified library insert is released from the plasmid backbone using unique restriction sites and used to transfect P. berghei. We demonstrate that using this method vector production can be scaled up to a 96-well plate format and show that recombineered vectors integrate into the P. berghei genome with increased efficiency because of their long homology arms. results A P. berghei genomic dnA library with medium size inserts We prepared libraries of size-selected P. berghei genomic DNA fragments in the bacteriophage N15-derived pJAZZ-OK vector from Lucigen 16 (Fig. 1a) . End-sequenced inserts of 5,109 clones could be mapped onto the P. berghei ANKA reference genome with high confidence, resulting in an arrayed library, named PbG01. The average insert size was 9.0 kb (range was 4.8-28.3 kb; Fig. 1b) .
The library contained 76% of P. berghei ANKA genes in their entirety and most genomic regions were covered by multiple clones (Fig. 1c) . All mapped clones can be viewed in the P. berghei genome browser of the PlasmoDB database 22 at http://plasmodb.org/plasmo/. The predicted G+C content of the library (22.59%) showed a small bias against (A+T)-rich genomic regions when compared to the genome assembly against which it was mapped (22.13% G+C content). We therefore compared actual clone coverage to that of a simulated random clone set with the same distribution of insert sizes as the actual library. This analysis confirmed gene coverage was not entirely random (Fig. 1d) . A curve fit to the data reached a plateau at ~95%, suggesting the remaining 5% of P. berghei genes may be unclonable in the bacteriophage N15-derived vector. To determine the extent of sequence integrity in the PbG01 library, we sequenced 39 nonoverlapping clones, totaling 332 kb of insert DNA, to >10× coverage. De novo assemblies contained no single-nucleotide polymorphisms, rearrangements, insertions or deletions when compared to the P. berghei ANKA reference genome, demonstrating that fragments of P. berghei DNA are stable in the pJAZZ vector.
A scalable pipeline to make genetic modification vectors We next asked whether bacteriophage N15-derived vector libraries can be modified like BACs in E. coli by exploiting homologous recombination-mediated by products of the red operon of bacteriophage lambda 17 . To convert PbG01 inserts into genetic modification vectors, we first made E. coli clones competent for homologous recombination by introducing a temperature-sensitive plasmid, pSC101gbaA-tet, encoding the bacteriophage λ red operon and E. coli recA 18 . Using homologous recombination in E. coli, we generated an intermediate vector, in which the gene of interest was replaced with a bicistronic marker cassette for positive and negative selection in E. coli, called zeo-PheS 21 that was flanked by Gateway attR1-attR2 sites (Fig. 2a) . The selection cassette conveys resistance to zeocin through the bleomycin resistance gene (Sh ble) from Streptoalloteichus hindustanus and sensitivity to p-chlorophenylalanine through a mutant allele of a phenylalanine tRNA synthase (pheS). Positive selection with zeocin yielded the intermediate vector. In the second stage, we used an in vitro Gateway LR (Invitrogen) reaction to exchange the bacterial marker by site-specific recombination for a much larger hdhfr-yFCU cassette for positive and negative selection in P. berghei 23 . We obtained the desired recombination product after negative selection on yeast extract glucose medium containing p-chlorophenylalanine (YEG-Cl).
Recombineering can be adapted to generate vectors for multiple genetic modification applications, including tagging, allele exchange and site-directed mutagenesis. To test this versatility, we developed a modified two-stage strategy for C-terminal protein tagging (Fig. 2b) . In this approach, we first inserted the zeo-PheS cassette immediately upstream of the stop codon, without modifying the open reading frame to be tagged. Then we introduced sequence encoding a triple hemagglutinin (3× HA) protein tag and a generic 3′ untranslated region (UTR) from the P. berghei dhfr-ts gene in frame with the upstream open reading frame in the Gateway step (Fig. 2b) . In contrast to conventional tagging strategies, in which the target locus is duplicated and will therefore revert to wild type at a low frequency 24 , recombineered tagging vectors are designed to integrate stably by an ends-out replacement mechanism. We tested the strategies to produce deletion and tagging vectors on 16 PbG01 clones (Supplementary Table 1 ) and verified each step by PCR genotyping. First we confirmed the presence of the gene of interest in each library insert by PCR (Fig. 2c) . Overnight liquid cultures selected with zeocin at 37 °C contained recombined plasmid ( Fig. 2c) and had eliminated the temperature-sensitive recombinase plasmid (data not shown). After the Gateway step, the first colony analyzed contained the desired recombination product for 14 of the 16 test genes. For one of the missing genes, screening additional colonies yielded the desired construct (data not shown). The unmodified library plasmid persisted in one culture (Fig. 2c) , presumably because phage N15-derived library vectors exist in about five copies per cell, not all of which recombine at stage 1. Counterselection on YEG-Cl had effectively eliminated the intermediate vector in all cases. As expected, the Gateway donor plasmid pR6K-3xHA, which could give rise to episomal resistance in P. berghei, was also lost (data not shown) because E. coli TSA (Lucigen) lack the pir gene required by the R6K origin of replication.
As with BACs 12,21 , recombineering on phage N15-derived vectors allowed sequential modification steps to be carried out in continuous liquid culture, that is, without intermediary isolation and characterization of single colonies. This suggested recombineering of P. berghei DNA could be scaled up from single tubes to 96-well plates. Using an optimized 8-d protocol ( Fig. 3 and  Supplementary Protocol 1) , we found that of 96 clones processed in parallel, 77 could be converted to genetic modification vectors (Supplementary Table 2 ). Retrospective analysis of all wells that contained clones that could not be converted showed that one TB kan, 37 °C
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Step library clone did not grow, one did not take up the recombinase plasmid, 15 did not recombine with the zeo-PheS cassette and two did not undergo the Gateway reaction. The majority of recombineering 'failures' (9 of 15) were due to mapping errors, which we rectified for the entire PbG01 library by remapping against the latest assembly of the P. berghei genome.
recombineered vectors modify the P. berghei genome
To test whether PbG01-based vectors can be used to modify P. berghei parasites, we released 14 modified genomic inserts from the vector backbone by digesting with NotI restriction endonuclease and transfected each into P. berghei schizonts. We obtained pyrimethamine-resistant parasites within 6 d and genotyped uncloned populations initially by Southern blot hybridization of separated chromosomes (Fig. 4a) . Each of 14 deletion and tagging constructs integrated into the predicted chromosome, and recombinants were the predominant genotype in all but one population (Fig. 4a) . We detected no false integration events or episomally maintained vector. Using longrange PCR we confirmed that PbG01-derived vectors had integrated by double homologous (ends-out) recombination. To assess the success of protein tagging we analyzed seven tagged lines by western blotting. Mobilities of tagged proteins were in satisfactory agreement with predictions, with the exception of one protein encoded by a gene with the identification number PBANKA_135150, which expressed as a much shorter fragment than expected (Fig. 4b) . Protein expression in some tagged lines was stage-specific ( Fig. 4b) and in all cases was consistent with gene expression patterns predicted by P. falciparum transcriptome data 25 . Immunofluorescence microscopy of genomically tagged parasite lines (Fig. 4c) showed the expected cellular localizations, for instance, for the cytosolic glycolytic enzyme phosphoglycerate kinase (PBANKA_082340) or a peripheral staining pattern for an alveolin (PBANKA_143660) associated with the inner membrane complex of the ookinete 26 .
long homology arms increase recombination frequency
Finally we examined whether the long homology arms of recombineered vectors increase recombination frequency. Using combinations of restriction enzymes, we reduced the homology arms of a deletion vector for the phosphodiesterase δ (pdeδ) gene (Fig. 5a ) and then transfected P. berghei schizonts with equimolar amounts of the digested vectors or with a conventional pdeδ deletion construct 27 with short (0.5 kb) homology arms. Recombination frequency was highly reproducible and increased linearly with the total length of homology arms (Fig. 5b) , suggesting that PbG01-derived, recombineered targeting vectors can boost transfection efficiency by about tenfold over traditional designs. discussion Our data show that serial, liquid recombineering in a 96-well format can be applied to (A+T)-rich P. berghei DNA in a phage N15-derived genomic library at a high overall efficiency (88.7%) that is sufficient to extend the production of genetic modification vectors to a large part of the genome. In designing our pipeline we opted for a two-stage approach because the zeo-PheS cassette used first is sufficiently small to be amplified robustly and with good yield by PCR. As a result, the recombineering step is reproducibly efficient, which is critical to minimize the amount of unrecombined low-copy plasmid that initially persists under zeocin selection. The zeo-PheS cassette acts as an exchange module for a P. berghei-specific cassette in a Gateway LR reaction. The in vitro exchange is followed by retransformation of E. coli, which functions as a critical purifying step that helps eliminate unreacted plasmid and unwanted minor reaction products, allowing clonal selection of final vectors before quality control.
As the Gateway reaction is not size-limited, the P. berghei selection module can be modified to incorporate other selection markers, protein tags and reporter genes. Our modular approach will thus enable researchers to select plasmids from a genomewide resource of intermediate vectors and readily convert these into customized gene-tagging and deletion alleles in a simple and scalable in vitro reaction. P. berghei is already an important in vivo model for the fundamental biology of malaria, in part because it enables access to the mosquito and liver stages of the life cycle, which are much less tractable in human parasites. A genomewide library of genetic modification vectors, combined with the flexibility and genetic tractability of the P. berghei model system, makes the genome-wide experimental analysis of gene function by targeted gene deletion and tagging a real possibility. online methods Clone availability. Library clones, recombineering tools and genetic modification vectors generated in the course of this study are available from the authors.
Parasites used. All transgenic P. berghei parasite were generated either in strain 2.34 ANKA wild type or in selectable marker-free reporter strains expressing the mu3 variant of green fluorescent protein (GFP; clone RMgm-7) or a fusion of GFP-mu3 and firefly luciferase (clone RMgm-29) 28 , generated in the same genetic background. Parasites were propagated in Theiler's Original (TO) outbred mice and were transmitted regularly through Anopheles stephensi. All animal research was conducted under licences issued by the UK Home Office using protocols reviewed by the ethics committee of the Wellcome Trust Sanger Institute. P. berghei genomic DNA library. The PbG01 library was constructed using the BigEasy v2.0 Linear Cloning System (Lucigen) essentially as described but with extra end-repair and gel-purification steps to increase cloning efficiency and 'tighten' insert size distribution. PbG01 clones were propagated in the BigEasy TSA bacterial strain (F-mcrA ∆(mrr-hsdRMSmcrBC) ϕ80dlacZ∆M15 ∆lacX74 endA1 recA1 araD139 ∆(ara, leu)7697 galU galK rpsL nupG λ-tonA bla (amp R ) sopAB telN antA, Lucigen) in TB medium with 0.4% glycerol plus 30 µg ml −1 kanamycin with or without arabinose induction. Ten micrograms of genomic DNA was sheared by 20 passages through a 30 G needle and end-repaired by incubation with 0.3 µl of mung bean nuclease (GE, 256 U µl −1 ) at 30 °C for 10 min before ethanol precipitation. DNA was pelleted by centrifugation, resuspended in 10 µl TE buffer, then size-selected through a 0.8% agarose gel. Fragments of 6-8 kb, 8-10 kb, 10-15 kb and 15-30 kb were excised, purified and end-repaired using the Lucigen kit reagents. A second gel size-selection was performed before each size class was ligated separately into pJAZZ vector overnight at 14 °C. After phenol-chloroform extraction with subsequent ethanol precipitation, each ligation was resuspended in 10 µl water and electroporated into BigEasy TSA (Lucigen) cells as recommended by the manufacturer. Cloning efficiency was high for fragments of 6-12 kb, with 91.3% of clones containing an insert (range 73.8-99.2%, n = 5 libraries), but this dropped to 62.7% for fragments of 12-30 kb (range 57.7-66.4%, n = 3 libraries).
Mapping of PbG01 clones. We subjected 13,702 P. berghei genomic inserts to capillary sequencing from both ends. Sequences were scanned for low-quality regions (Phred score < 10 in 40-nt window) and trimmed or removed accordingly using custom scripts. Sequences matching the cloning vector were removed. Remaining insert ends were mapped to the P. berghei assembly version of January 2011 (ftp://ftp.sanger.ac.uk/pub/ pathogens/P_berghei/January_2011/) using the Smalt mapping software (http://www.sanger.ac.uk/resources/software/smalt/), allowing only uniquely mapping paired ends with a minimum Smith-Waterman mapping score of 200 and distance between clone ends consistent with the size selection steps during library preparation to within 20%. Artemis 29 was used for visualising clones mapping to the genome. To view clones covering a genomic region of interest in the PlasmoDB genome browser (http://plasmodb.org/cgi-bin/gbrowse/plasmodb), enter "http:// das.sanger.ac.uk/das/pbg" into the box labeled "Enter Remote Annotation URL", click "update" and select a P. berghei genome region to view (for example, "berg01:1000..20000"). Sequences of selected PbG01 clones were verified in their entirety by sequencing pooled plasmids on one lane of an Illumina Genome Analyser II. The obtained reads were assembled with velvet 30 , version 0.7.63. All resulting contigs were ordered using algorithm-based automatic contiguation of assembled sequences (ABACAS) 31 against the reference genome, visualized for manual inspection in the Artemis Comparison Tool and analyzed for differences to the reference using SAMtools and BCFtools 32 with default parameters.
Plasmids for recombineering and Gateway reaction. Plasmid pR6K attR1-zeo-PheS-attR2 (ref. 21 ) for amplification of the zeo-PheS cassette contains the R6K origin of replication and was propagated in E. coli PIR1 (Invitrogen) bacteria (F-∆lac169 rpoS(Am) robA1 creC510 hsdR514 endA recA1 uidA (∆MluI):: pir-116) in LB broth with 10 µg ml −1 tetracycline. pSC101gbdA 18 was propagated at 30 °C in DH10B cells in LB broth with 5 µg ml −1 tetracycline or together with pJAZZ library clones in TB medium with 0.4% glycerol, 30 µg ml −1 kanamycin and 5 µg ml −1 tetracycline.
The Gateway donor plasmid pR6K attL1-3xHA-hdhfr-yfcuattL2 (Supplementary Fig. 1 ) was assembled in an R6K plasmid backbone containing a tetracycline resistance cassette. A DNA fragment composed of 3× HA tag and 452 bp of Pbdhfr 3′ UTR flanked by attL1 and attL2 sites was synthesized by Geneart. An expression cassette for hdhfr-yfcu was subcloned from pL0035 (ref. 23 ) via PstI and Acc65I restriction sites. Both R6K vectors were propagated in PIR1 cells. A detailed protocol for 96-well recombineering is given in Supplementary Protocol 1.
